BACKGROUND: Diarrheal disease remains a major contributor to morbidity and mortality in Africa, but host defense against intestinal infection is poorly understood and may depend on nutritional status. OBJECTIVE: To test the hypothesis that defense against intestinal infection depends on micronutrient status, we undertook a randomized controlled trial of multiple micronutrient supplementation in a population where there is borderline micronutrient deficiency. DESIGN:All consenting adults (> or =18 y) living in a carefully defined sector of Misisi, Lusaka, Zambia, were included in a cluster-randomized (by household), double-blind, placebo-controlled trial with a midpoint crossover. There were no exclusion criteria. Participants were given a daily tablet containing 15 micronutrients at just above the recommended nutrient intake or placebo. The primary endpoint was the incidence of diarrhea; secondary endpoints were severe episodes of diarrhea, respiratory infection, nutritional status, CD4 count, and mortality. RESULTS:Five hundred participants were recruited and followed up for 3.3 y (10,846 person-months). The primary endpoint, incidence of diarrhea (1.4 episodes/y per person), did not differ with treatment allocation. However, severe episodes of diarrhea were reduced in the supplementation group (odds ratio: 0.50; 95% CI: 0.26, 0.92; P = 0.017). Mortality was reduced in HIV-positive participants from 12 with placebo to 4 with supplementation (P = 0.029 by log-rank test), but this was not due to changes in CD4 count or nutritional status. CONCLUSION:Micronutrient supplementation with this formulation resulted in only modest reductions in severe diarrhea and reduced mortality in HIV-positive participants. The trial was registered as ISRCTN31173864.
RCT Entities:
BACKGROUND:Diarrheal disease remains a major contributor to morbidity and mortality in Africa, but host defense against intestinal infection is poorly understood and may depend on nutritional status. OBJECTIVE: To test the hypothesis that defense against intestinal infection depends on micronutrient status, we undertook a randomized controlled trial of multiple micronutrient supplementation in a population where there is borderline micronutrient deficiency. DESIGN: All consenting adults (> or =18 y) living in a carefully defined sector of Misisi, Lusaka, Zambia, were included in a cluster-randomized (by household), double-blind, placebo-controlled trial with a midpoint crossover. There were no exclusion criteria. Participants were given a daily tablet containing 15 micronutrients at just above the recommended nutrient intake or placebo. The primary endpoint was the incidence of diarrhea; secondary endpoints were severe episodes of diarrhea, respiratory infection, nutritional status, CD4 count, and mortality. RESULTS: Five hundred participants were recruited and followed up for 3.3 y (10,846 person-months). The primary endpoint, incidence of diarrhea (1.4 episodes/y per person), did not differ with treatment allocation. However, severe episodes of diarrhea were reduced in the supplementation group (odds ratio: 0.50; 95% CI: 0.26, 0.92; P = 0.017). Mortality was reduced in HIV-positive participants from 12 with placebo to 4 with supplementation (P = 0.029 by log-rank test), but this was not due to changes in CD4 count or nutritional status. CONCLUSION: Micronutrient supplementation with this formulation resulted in only modest reductions in severe diarrhea and reduced mortality in HIV-positive participants. The trial was registered as ISRCTN31173864.
Authors: Nyagosya Range; John Changalucha; Henrik Krarup; Pascal Magnussen; Ase B Andersen; Henrik Friis Journal: Br J Nutr Date: 2006-04 Impact factor: 3.718
Authors: Jeffrey S A Stringer; Isaac Zulu; Jens Levy; Elizabeth M Stringer; Albert Mwango; Benjamin H Chi; Vilepe Mtonga; Stewart Reid; Ronald A Cantrell; Marc Bulterys; Michael S Saag; Richard G Marlink; Alwyn Mwinga; Tedd V Ellerbrock; Moses Sinkala Journal: JAMA Date: 2006-08-16 Impact factor: 56.272
Authors: Jon D Kaiser; Adriana M Campa; Joseph P Ondercin; Gifford S Leoung; Richard F Pless; Marianna K Baum Journal: J Acquir Immune Defic Syndr Date: 2006-08-15 Impact factor: 3.731
Authors: Paul Kelly; Ian Menzies; Roger Crane; Isaac Zulu; Carole Nickols; Roger Feakins; James Mwansa; Victor Mudenda; Max Katubulushi; Steve Greenwald; Michael Farthing Journal: Am J Trop Med Hyg Date: 2004-04 Impact factor: 2.345
Authors: Wafaie W Fawzi; Gernard I Msamanga; Donna Spiegelman; Ruilan Wei; Saidi Kapiga; Eduardo Villamor; Davis Mwakagile; Ferdinand Mugusi; Ellen Hertzmark; Max Essex; David J Hunter Journal: N Engl J Med Date: 2004-07-01 Impact factor: 91.245
Authors: Caroline S Broome; Francis McArdle; Janet A M Kyle; Francis Andrews; Nicola M Lowe; C Anthony Hart; John R Arthur; Malcolm J Jackson Journal: Am J Clin Nutr Date: 2004-07 Impact factor: 7.045
Authors: Steven Y Hong; Kristy M Hendricks; Christine Wanke; Gloria Omosa; Shem Patta; Ben Mwero; Innocent Mjomba; Jeanette Queenan; Mkaya Mwamburi Journal: Public Health Nutr Date: 2012-09-14 Impact factor: 4.022
Authors: Winnie Dhaliwal; Tamara Shawa; Moriam Khanam; Poonam Jagatiya; Michelo Simuyandi; Namwiinga Ndulo; Charles L Bevins; Ian R Sanderson; Paul Kelly Journal: J Infect Dis Date: 2010-09-15 Impact factor: 5.226
Authors: Reena Rajasuriar; Gabriela Khoury; Adeeba Kamarulzaman; Martyn A French; Paul U Cameron; Sharon R Lewin Journal: AIDS Date: 2013-05-15 Impact factor: 4.177
Authors: Paul Kelly; Tamara Shawa; Stayner Mwanamakondo; Rose Soko; Geoff Smith; G Robin Barclay; Ian R Sanderson Journal: BMC Gastroenterol Date: 2010-07-06 Impact factor: 3.067